July 10.2020
AVATAMED Partners CBmed in Europe on Precision Cancer Project
We are pleased to annouce the partnership with CBmed in Europe on a Precision Cancer Project. Leveraging on AVATAMED's drug screening and genomic data analysis technology, the partnership will advance this joint effort to the rest of Europe through engagement with the oncology industry and pharmaceutical companies.
July 10.2020
- Attachments
- AVATAMED_CBmed_Press_Release.pdf